Stocks-VBIV-VBI Vaccines Inc

VBIV VBI Vaccines Inc

0.5780 -0.0124 (-2.10%)
Invest
Invest

Overview

Prev Close0.5780
Day's Range 0.5400 - 0.5771
52 Week Range 0.5398 - 3.39
Average Volume (3m)818.38K
1-Year Return-79.93%
Beta1.241
Market Cap149.27M
P/E Ratio
Revenue870K
EPS-0.4298
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.715/06/202226/08/202207/11/20220.60000.80001.00001.20001.4000
Chart times in UTC
Industry Biotechnology
CEO Jeff Baxter
Employees 127

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: VBI Vaccines Inc's revenues decreased by 40.53% and amounted to 631.00K. Net income decreased by 50.88% to -69.75M. Net assets decreased by 16.20% to 143.88M and EPS decreased from -0.21 to -0.27.
VBIV's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-1,419.20%
Net Profit Margin
-4,856.66%
Operating Margin
-11,321.06%
Return On Investment
-42.58%
12/21
03/22
06/22
09/22
Total Revenue
81K
126K
346K
317K
Gross Profit
-3.65M
-3.1M
-2.72M
-2.88M
Operating Income
-20.87M
-15.92M
-22.9M
-21.56M
Net Income
-18.78M
-21.25M
-45.7M
-25.21M